1. Home
  2. VIRT vs INDV Comparison

VIRT vs INDV Comparison

Compare VIRT & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtu Financial Inc.

VIRT

Virtu Financial Inc.

HOLD

Current Price

$57.71

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$37.96

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRT
INDV
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
4.7B
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
VIRT
INDV
Price
$57.71
$37.96
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$45.60
N/A
AVG Volume (30 Days)
1.1M
1.4M
Earning Date
04-29-2026
06-08-2026
Dividend Yield
1.89%
N/A
EPS Growth
72.73
8100.00
EPS
3.62
0.69
Revenue
$3,632,118,000.00
$1,239,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.34
N/A
P/E Ratio
$29.51
$57.99
Revenue Growth
26.25
4.29
52 Week Low
$31.55
$21.16
52 Week High
$68.02
$42.81

Technical Indicators

Market Signals
Indicator
VIRT
INDV
Relative Strength Index (RSI) 46.27 40.74
Support Level $56.14 $38.47
Resistance Level $60.97 $41.88
Average True Range (ATR) 2.22 1.54
MACD -0.34 -0.24
Stochastic Oscillator 56.84 23.98

Price Performance

Historical Comparison
VIRT
INDV

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: